Isolation of ovarian cancer circulating tumor cells using an epitope independent microfluidic cell capture device and their interrogation using a multiplex gene expression assay or immunofluorescence
Gynecologic Oncology(2020)
Abstract
Objective: The current study was designed to evaluate the ability of an epitope independent microfluidic cell capture device to isolate circulating tumor cells (CTCs) from the blood of women with stage III–IV high-grade serous ovarian cancer (HGSOC) that could subsequently be evaluated using either a highly multiplexed gene expression assay or by immunofluorescence (IF).
MoreTranslated text
Key words
ovarian cancer,tumor cells,multiplex gene expression
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined